juglone has been researched along with Acute Confusional Senile Dementia in 7 studies
juglone: structure
juglone : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone in which the hydrogen at position 5 has been replaced by a hydroxy group. A plant-derived 1,4-naphthoquinone with confirmed antibacterial and antitumor activities.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amyloid-β, one of the hallmarks of Alzheimer's disease, is toxic to neurons and causes cell death in the brain." | 1.43 | Cratoxylum formosum Extract Protects against Amyloid-Beta Toxicity in a Caenorhabditis elegans Model of Alzheimer's Disease. ( Keowkase, R; Weerapreeyakul, N, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Necula, M | 1 |
| Kayed, R | 1 |
| Milton, S | 1 |
| Glabe, CG | 1 |
| Keowkase, R | 1 |
| Weerapreeyakul, N | 1 |
| Bermejo-Bescós, P | 1 |
| Martín-Aragón, S | 1 |
| Jiménez-Aliaga, KL | 1 |
| Ortega, A | 1 |
| Molina, MT | 1 |
| Buxaderas, E | 1 |
| Orellana, G | 1 |
| Csákÿ, AG | 1 |
| Nykänen, NP | 1 |
| Kysenius, K | 1 |
| Sakha, P | 1 |
| Tammela, P | 1 |
| Huttunen, HJ | 1 |
| Hamdane, M | 2 |
| Smet, C | 1 |
| Sambo, AV | 1 |
| Leroy, A | 1 |
| Wieruszeski, JM | 1 |
| Delobel, P | 1 |
| Maurage, CA | 1 |
| Ghestem, A | 1 |
| Wintjens, R | 1 |
| Bégard, S | 2 |
| Sergeant, N | 1 |
| Delacourte, A | 1 |
| Horvath, D | 1 |
| Landrieu, I | 1 |
| Lippens, G | 1 |
| Buée, L | 2 |
| Galas, MC | 1 |
| Dourlen, P | 1 |
| Ando, K | 1 |
| Blum, D | 1 |
| Kesavapany, S | 1 |
| Patel, V | 1 |
| Zheng, YL | 1 |
| Pareek, TK | 1 |
| Bjelogrlic, M | 1 |
| Albers, W | 1 |
| Amin, N | 1 |
| Jaffe, H | 1 |
| Gutkind, JS | 1 |
| Strong, MJ | 1 |
| Grant, P | 1 |
| Pant, HC | 1 |
7 other studies available for juglone and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Humans; Plaque, Amyloid; Protein Structu | 2007 |
Cratoxylum formosum Extract Protects against Amyloid-Beta Toxicity in a Caenorhabditis elegans Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Antioxidants; Caen | 2016 |
In vitro antiamyloidogenic properties of 1,4-naphthoquinones.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Aspartic Ac | 2010 |
γ-Aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation.
Topics: Alzheimer Disease; Animals; Cell Line, Tumor; Cyclin-Dependent Kinase 5; Cytoskeleton; Enzyme Inhibi | 2012 |
Pin1: a therapeutic target in Alzheimer neurodegeneration.
Topics: Alzheimer Disease; Cell Line; Cyclin D1; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; | 2002 |
The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease.
Topics: Adaptor Proteins, Signal Transducing; Alzheimer Disease; Animals; Catalysis; Enzyme Activation; Enzy | 2006 |
Inhibition of Pin1 reduces glutamate-induced perikaryal accumulation of phosphorylated neurofilament-H in neurons.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Apoptosis; Cell Nucleus; Ganglia, Spinal; | 2007 |